Sabra Health Care REIT, Inc. (NASDAQ:SBRA – Get Free Report) has received a consensus rating of “Moderate Buy” from the seven brokerages that are covering the firm, MarketBeat reports. Three research analysts have rated the stock with a hold recommendation, three have given a buy recommendation and one has given a strong buy recommendation to the company. The average 12-month target price among analysts that have issued a report on the stock in the last year is $19.33.
SBRA has been the subject of a number of analyst reports. Mizuho restated a “neutral” rating and issued a $20.00 price objective on shares of Sabra Health Care REIT in a research note on Thursday, December 5th. JMP Securities upgraded shares of Sabra Health Care REIT from a “market perform” rating to an “outperform” rating and set a $20.00 price target for the company in a report on Tuesday, January 7th. Truist Financial lifted their price objective on Sabra Health Care REIT from $17.00 to $18.00 and gave the stock a “hold” rating in a research note on Tuesday, March 18th. Finally, Citizens Jmp upgraded Sabra Health Care REIT from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, January 7th.
View Our Latest Stock Analysis on SBRA
Institutional Trading of Sabra Health Care REIT
Sabra Health Care REIT Trading Up 0.9 %
Shares of NASDAQ:SBRA opened at $17.54 on Monday. The company has a current ratio of 4.32, a quick ratio of 4.16 and a debt-to-equity ratio of 0.88. The stock has a market capitalization of $4.17 billion, a PE ratio of 33.09, a P/E/G ratio of 1.97 and a beta of 1.27. Sabra Health Care REIT has a 1 year low of $13.31 and a 1 year high of $20.03. The firm has a fifty day moving average price of $16.83 and a 200 day moving average price of $17.67.
Sabra Health Care REIT (NASDAQ:SBRA – Get Free Report) last released its quarterly earnings results on Wednesday, February 19th. The real estate investment trust reported $0.36 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.36. Sabra Health Care REIT had a return on equity of 4.60% and a net margin of 18.02%. The company had revenue of $182.35 million during the quarter, compared to the consensus estimate of $178.01 million. Analysts expect that Sabra Health Care REIT will post 1.45 EPS for the current fiscal year.
Sabra Health Care REIT Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Friday, February 28th. Investors of record on Friday, February 14th were paid a dividend of $0.30 per share. The ex-dividend date of this dividend was Friday, February 14th. This represents a $1.20 annualized dividend and a yield of 6.84%. Sabra Health Care REIT’s dividend payout ratio is 226.42%.
About Sabra Health Care REIT
Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.
Featured Stories
- Five stocks we like better than Sabra Health Care REIT
- Comparing and Trading High PE Ratio Stocks
- Venezuelan Tariffs Could Power These 3 Diesel-Driven Winners
- Trading Stocks: RSI and Why it’s Useful
- MarketBeat Week in Review – 03/24 – 03/28
- What is the S&P/TSX Index?
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
Receive News & Ratings for Sabra Health Care REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Health Care REIT and related companies with MarketBeat.com's FREE daily email newsletter.